Monoclonal Antibody for Ewing's Sarcoma
Author Information
Author(s): S. Haral, E. Ishii, S. Tanaka, J. Yokoyama, K. Katsumata, J. Fujimoto, J. Hata
Primary Institution: National Children's Medical Research Centre; Keio University School of Medicine
Hypothesis
Can a specific monoclonal antibody be developed to distinguish Ewing's sarcoma from other childhood tumors?
Conclusion
The monoclonal antibody 5C11 specifically reacts with Ewing's sarcoma and not with other small round cell tumors, indicating its potential for diagnosis and treatment.
Supporting Evidence
- 5C11 specifically reacted with Ewing's sarcoma but not with other childhood tumors.
- 5C11 did not react with normal tissues except for fetal hepatocytes.
- Immunoelectron microscopy showed 5C11 antigen localized on the cell membrane of Ewing's sarcoma cells.
Takeaway
Scientists created a special antibody that can find a type of cancer called Ewing's sarcoma, helping doctors tell it apart from other similar cancers.
Methodology
Mouse monoclonal antibodies were developed by injecting Ewing's sarcoma cells into mice and screening for specific reactivity.
Limitations
The study does not address the long-term effectiveness of the antibody in clinical settings.
Participant Demographics
Included various ages and sexes of children with Ewing's sarcoma.
Want to read the original?
Access the complete publication on the publisher's website